Skip to main content
Toggle navigation
Search
Home
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
D
D Silva, Riyona
Manipal Academy of Higher Education, Manipal
(
23
)
Estimation and Prediction of Length of Stay using Artificial Neural Networks in Rheumatoid Arthritis in a Tertiary Care Hospital
Riyona D Silva
Damase-Michel, Christine
Université Toulouse III
(
33
)
Identification and prevalence assessment of multiple sclerosis in women: a multicentre database study across Europe: A contribution from the IMI2 ConcePTION project
Christine Damase-Michel
Dauner, Dan
University of Minnesota
(
05
)
Evaluation of Four Machine Learning Models for Signal Detection
Dan Dauner
Davey Smith, George
University of Bristol
(
28
)
Implementing Mendelian Randomization to Assess Foetal Risk from Intrauterine Prescriptive Drugs for the Treatment of Diabetes, Hypertension and Thyroidism in Pregnancy
George Davey Smith
Davies, Neil
University of Bristol
(
28
)
Implementing Mendelian Randomization to Assess Foetal Risk from Intrauterine Prescriptive Drugs for the Treatment of Diabetes, Hypertension and Thyroidism in Pregnancy
Neil Davies
de Bruin, Odette
UMCU
(
31
)
Evolution of the national guidelines on the medicines used to treat COVID-19 in pregnancy in 2020-2021: a historical review
Odette de Bruin
Deng, Siwei
Department of Epidemiology and Biostatistics, School of Public Health, Peking University
(
07
)
Validation and algorithm for children intussusception identification using electronic health records of Ningbo city in China
Siwei Deng
Desplas, David
EPI-PHARE (Scientific Interest Group in Epidemiology of Health Products), French National Agency for the Safety of Medicines and Health Products, French National Health Insurance, CEDEX, 93285 Saint-Denis, France.
(
08
)
Identification of factors associated with severe SARS-Cov2 infection for patients treated with MS-specific disease-modifying therapies
David Desplas
Donati, Serena
Women, Child and Adolescent Health Unit (National Centre for Disease Prevention and Health Promotion)
(
31
)
Evolution of the national guidelines on the medicines used to treat COVID-19 in pregnancy in 2020-2021: a historical review
Serena Donati
Back to Top
